Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
11 May 2026, 16:32:42 UTC
Prior SEC filing
04 Jun 2025
Next SEC filing
04 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Mark Enyedy

Key filing fact

Mark J. Enyedy filed Form 4 for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) on 11 May 2026.

Key facts

  • This page summarizes Mark J. Enyedy's Form 4 filing for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 11 May 2026, 16:32.

Change

  • Previous filing in this sequence was filed on 04 Jun 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001586965 Primary reporting owner

Enyedy Mark J

Relationship
Director
Address
C/O CHARLES RIVER LABORATORIES, 251 BALLARDVALE STREET, WILMINGTON
Signature
/s/ Mark Enyedy
Signature date
11 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRL transaction

Common Stock

Award

Transaction value
Shares
+1,438
Change %
+152%
Price
$177.62*
Shares after
2,384
Date
08 May 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The unvested restricted stock units vest upon the earlier of 5/8/2027 or the business day prior to the Company's next annual meeting of shareholders.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .